Sitemap
October 13, 2023 Articles
Filter by Available Specialty
- ‘One giant leap for HCM’: Gene therapy may reverse hypertrophic cardiomyopathy
- ‘Pain is the most important symptom’: Helping patients navigate the dangers of OTC NSAIDs
- Adding oral piroxicam to levonorgestrel improves emergency contraception efficacy
- Affordable Care Act increased cancer trial participation among Medicaid-insured patients
- Amlitelimab shows promise as treatment for moderate to severe atopic dermatitis
- Antidepressant use after diagnosis may reduce liver cancer mortality
- APA condemns attacks on Israel, offers mental health resources
- Better fertility information needed for adolescent, young adult cancer survivors
- Despite panel support, FDA rejects patisiran for ATTR amyloidosis with cardiomyopathy
- FDA approves expanded indication of spinal cord stimulation therapy
- FDA approves Pfizer’s Velsipity as ‘oral, once-daily pill’ for ulcerative colitis
- FDA clears cataract, cornea, metric features of Anterion platform
- FDA clears next-generation AI-powered ECG monitoring device
- FDA clears third IND for Kyverna’s CAR T-cell drug to treat systemic sclerosis
- FDA issues marketing denial order for popular flavored e-cigarette products
- Fenebrutinib linked to reduced lesion activity, higher CSF penetration in MS at 12 weeks
- Live from OSN New York 2023
- Multicancer detection tests show promise, but questions linger about their accessibility
- Open communication with providers may improve dietary adherence in patients on dialysis
- Patient engagement with daily pulmonary artery pressure readings shows benefit in HF
- PCR testing for congenital CMV produces ‘delightfully surprising’ results
- Phase 3 results show Vtama rapidly reduces itch in children, adults with atopic dermatitis
- PIVOT outcomes have not changed US surgeons’ preference for pars plana vitrectomy
- Q&A: Vaping dependence linked to higher depression risk in young people
- Q&A: Providers must listen, recognize GI ‘alarm signals’ in pediatric patients
- ReBokeh app redefines role of assistive technology for moderate vision impairment
- Researchers characterize ECMO use, patient outcomes during COVID-19 pandemic
- Reviews weigh benefits, harms of topical, systemic treatments for atopic dermatitis
- Substance abuse in OSA raises odds for cardiovascular, cerebrovascular events
- SURMOUNT-3, keynote lectures highlight program at ObesityWeek
- Tezepelumab reduces asthma exacerbations regardless of BMI
- Top in allergy/asthma: FDA updates cross-contact guidelines; cat allergy lozenge
- Tubeless hybrid closed-loop system boosts time in range for youths with type 1 diabetes
- Video distraction minimizes anesthesia for children undergoing radiotherapy
- VIDEO: ‘We do better when we work together’
- VIDEO: ‘You might not be as much in a silo as you think’
- VIDEO: CooperVision contact lens research supports utility of new technologies
- VIDEO: Doctors, patients provide positive feedback on Acuvue Max daily disposable contacts
- VIDEO: ID physicians can help expand availability, health of donor organs
- VIDEO: Optogenetic therapy shows promise in advanced retinitis pigmentosa
- VIDEO: Osimertinib after chemoradiation may benefit EGFR-mutated advanced NSCLC
- VIDEO: Osimertinib plus chemotherapy may benefit some lung cancer subsets
- VIDEO: Second-line tepotinib plus osimertinib benefits metastatic EGFR-mutated NSCLC
- VIDEO: Several options available to manage residual astigmatism
- VIDEO: Surgery ‘not for everyone’ with mesothelioma, not linked to better outcomes
- VIDEO: What to know about CDC’s draft guidance on doxy-PEP